Study of Topical Ocular PAN-90806 in PDR
NCT02475109
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Retinopathy
Interventions
DRUG:
PAN-90806 Ophthalmic Solution
Sponsor
PanOptica, Inc.